Citation: | Daniyaer Nuerdebieke, Subinuer Yizihaer, Abudureheman Zebibula, QIAO Bingzhang, Mulati Rexiati. Correlation analysis of inflammation and nutritional indicators with prognosis in patients after radical cystectomy[J]. Chinese Journal of General Practice, 2024, 22(8): 1300-1304. doi: 10.16766/j.cnki.issn.1674-4152.003621 |
[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. doi: 10.3322/caac.21492
|
[2] |
XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J (Engl), 2022, 135(5): 584-590. doi: 10.1097/CM9.0000000000002108
|
[3] |
SZABADOS B, KOCKX M, ASSAF Z J, et al. Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder[J]. Eur Urol, 2022, 82(2): 212-222. doi: 10.1016/j.eururo.2022.04.013
|
[4] |
HE K, SI L X, PAN X H, et al. Preoperative systemic immune-inflammation index (SII) as a superior predictor of long-term survival outcome in patients with stage Ⅰ-Ⅱ gastric cancer after radical surgery[J]. Front Oncol, 2022, 12: 829689. DOI: 10.3389/fonc.2022.829689.
|
[5] |
LI J Z, CAO D H, HUANG Y, et al. The prognostic and clinicopathological significance of systemic immune-inflammation index in bladder cancer[J]. Front Immunol, 2022, 13: 865643. DOI: 10.3389/fimmu.2022.865643.
|
[6] |
周阳阳, 刘静, 朱叶青, 等. 全身免疫炎症指数对HER2阴性晚期胃癌患者一线化疗疗效及生存结局的预测价值[J]. 中华全科医学, 2023, 21(12): 2031-2035. doi: 10.16766/j.cnki.issn.1674-4152.003283
ZHOU Y Y, LIU J, ZHU Y Q, et al. Predictive value of systemic immunoinflammatory index for first-line chemotherapy efficacy and survival outcome in patients with HER2-negative advanced gastric cancer[J]. Chinese Journal of General Practice, 2023, 21(12): 2031-2035. doi: 10.16766/j.cnki.issn.1674-4152.003283
|
[7] |
苏比努尔·依孜哈尔, 达尼亚尔·努尔德别克, 玛依努尔·艾力. 炎症及营养指标与食管癌患者预后相关性分析[J]. 中国临床医生杂志, 2024, 52(1): 39-43.
SUBINUER Y, DANIYAER N, MAYINUER A. Analysis of the correlation between inflammation and nutrition indexes and prognosis of patients with esophageal cancer[J]. Chinese Journal of Clinicians, 2019, 52(1): 39-43.
|
[8] |
GRETEN F R, GRIVENNIKOV S I. Inflammation and cancer: triggers, mechanisms, and consequences[J]. Immunity, 2019, 51(1): 27-41. doi: 10.1016/j.immuni.2019.06.025
|
[9] |
CHANG Z L, LI R Q, ZHANG J H, et al. Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients[J]. Front Immunol, 2022, 13: 1008865. DOI: 10.3389/fimmu.2022.1008865.
|
[10] |
DU X Y, DONG J, YAN K, et al. Novel nomograms predicting the survival of patients with nonsurgical thoracic esophageal squamous cell carcinoma treated with IMRT: a retrospective analysis[J]. Medicine, 2022, 101(40): e30305. DOI: 10.1097/MD.0000000000030305.
|
[11] |
GULLER M, HERBERG M, AMIN N, et al. Nutritional status as a predictive biomarker for immunotherapy outcomes in advanced head and neck cancer[J]. Cancers, 2021, 13(22): 5772. DOI: 10.3390/cancers13225772.
|
[12] |
杨丽萍, 吴爱林, 周燕, 等. 放疗前NLR和PLR对局部晚期鼻咽癌患者预后的影响[J]. 中华全科医学, 2022, 20(9): 1458-1461, 1534. doi: 10.16766/j.cnki.issn.1674-4152.002622
YANG L P, WU A L, ZHOU Y, et al. Effect of NLR and PLR before radiotherapy on prognosis of patients with locally advanced nasopharyngeal carcinoma[J]. Chinese Journal of General Practice, 2022, 20(9): 1458-1461, 1534. doi: 10.16766/j.cnki.issn.1674-4152.002622
|
[13] |
陈莉, 汪涌, 祝广峰, 等. 2020年欧洲泌尿协会肌层浸润性膀胱癌诊断和治疗指南概要[J]. 现代泌尿外科杂志, 2020, 25(11): 1025-1029.
CHEN L, WANG Y, ZHU G F, et al. 2020 European Urological Association guidelines for the diagnosis and treatment of myoinvasive bladder cancer[J]. Journal of Modern Urology, 20, 25(11): 1025-1029.
|
[14] |
淡一航, 张宇, 杨岭, 等. 全身免疫炎症指数在急性冠状动脉综合征中的应用进展[J]. 中国心血管病研究, 2023, 21(11): 1038-1042.
DAN Y H, ZHANG Y, YANG L, et al. Application of systemic immunoinflammatory index in acute coronary syndrome[J]. Chinese Journal of Cardiovascular Diseases, 2023, 21(11): 1038-1042.
|
[15] |
GORGEL S N, AKIN Y, KOC E M, et al. Retrospective study of systemic immune-inflammation index in muscle invasive bladder cancer: initial results of single centre[J]. Int Urol Nephrol, 2020, 52(3): 469-473.
|
[16] |
ZHANG X P, LIU Q. Systemic immune inflammation index and T-staging predict prognosis in patients with muscle-invasive bladder cancer[J]. Arch Esp Urol, 2023, 76(7): 511-518.
|
[17] |
孙祖刚, 刘硕, 王哲, 等. 术前外周血血小板与淋巴细胞比值在评估膀胱癌根治术患者预后中的临床价值[J]. 临床泌尿外科杂志, 2019, 34(4): 284-288.
SUN Z G, LIU S, WANG Z, et al. The clinical value of preoperative peripheral blood platelet to lymphocyte ratio in evaluating the prognosis of patients with bladder cancer undergoing radical surgery[J]. Journal of Clinical Urology, 2019, 34(4): 284-288.
|
[18] |
LIU Q, MA Z M, CAO Q, et al. Perineural invasion-associated biomarkers for tumor development[J]. Biomed Pharmacother, 2022, 155: 113691. DOI: 10.1016/j.biopha.2022.113691.
|
[19] |
OKADOME K, BABA Y, YAGI T, et al. Prognostic nutritional index, tumor-infiltrating lymphocytes, and prognosis in patients with esophageal cancer[J]. Ann Surg, 2020, 271(4): 693-700.
|
[20] |
WANG J C, SHI H J, FAN Z N, et al. Prognostic nutritional index combined with NLR to construct a survival prediction model and decision analysis of patients with muscle-invasive bladder cancer after surgery[J]. Cancer Med, 2023, 12(13): 14207-14224.
|
[21] |
唐文超, 李远伟, 陈佳, 等. 预后营养指数评估根治性膀胱切除术患者预后的Meta分析[J]. 肿瘤防治研究, 2021, 48(9): 871-876.
TANG W C, LI Y W, CHEN J, et al. Prognostic nutritional index: a meta-analysis of prognosis in patients with radical cystectomy[J]. Cancer Prevention and Treatment Research, 2019, 48(9): 871-876.
|
[22] |
李东辉, 李杰, 王艳伟, 等. 系统免疫炎症指数、预后营养指数对老年食管癌根治性放疗后死亡的预测价值[J]. 浙江医学, 2023, 45(15): 1621-1625.
LI D H, LI J, WANG Y W, et al. Value of systemic immunoinflammatory index and prognostic nutrition index in predicting death of elderly esophageal cancer after radical radiotherapy[J]. Zhejiang Medical Journal, 2023, 45(15): 1621-1625.
|